The SPG7 gene helps make paraplegin, a protein that keeps mitochondria, the cell’s energy centers, working properly in nerve and muscle cells. This gene plays an important role in clearing damaged proteins inside these energy centers. When it does not work well, energy-hungry cells may become stressed over time. People with harmful variants in both copies of the SPG7 gene can develop SPG7-related hereditary spastic paraplegia, which often causes leg stiffness, walking difficulty, balance problems, and sometimes vision or coordination changes.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are involved mainly in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes help guide how your body develops and works, and they can affect how you respond to food, stress, and medications. To explore this subject in more depth, you can learn more in the LearnHub.
Overview
SPG7Gene function
What if the gene works
The SPG7 gene helps mitochondria, the parts of cells that make energy, stay healthy by clearing damaged proteins. This is especially important for nerve and muscle cells, which depend on a steady energy supply.
Risk
What if the gene does not work
Variants in the SPG7 gene can lead to stiffness and weakness in the legs, balance problems, and sometimes vision changes. Effects range from mild to more severe, and different variants may influence when symptoms begin and which features appear.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the SPG7 gene, no treatment or drug choice specific to SPG7 is currently established in clinical guidelines. The SPG7 gene is being studied in early mitochondrial therapy research, but this has not yet changed routine care.
Conditions associated with SPG7
Gene function
What if the gene works
The SPG7 gene helps care for mitochondria, the parts of cells that make most of your energy. Its protein works inside these energy centers to keep key proteins in good shape and support steady day to day cell function. Understanding SPG7 gene function helps show how cells maintain a reliable energy supply.
The SPG7 gene helps form a protein quality control system inside mitochondria. This system cuts up worn out or misplaced proteins so they do not build up and disrupt normal cell work.
Some mitochondrial proteins need trimming before they can do their jobs well. The SPG7 gene helps with this step, so important proteins can settle into the right form inside the cell's energy centers.
By maintaining mitochondrial proteins, the SPG7 gene supports steady energy production in many tissues. This is especially important in cells with high energy needs, such as nerve and muscle cells.
Inside the inner membrane of mitochondria, SPG7 works with partner proteins to keep this structure organized and efficient. This helps the cell's energy machinery run in a stable, coordinated way.
What is a variant?
A genetic variant is a slight change in a gene’s DNA sequence. These changes are common and help explain normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SPG7 gene can change the paraplegin protein so it is shortened, unstable, or less able to join partner proteins inside mitochondria, the parts of cells that make energy. In this way, SPG7 gene variants may reduce how well cells clear damaged proteins, and some changes disrupt this process more than others. Milder variants can leave some activity, while more severe variants can cause greater loss of function and are often linked to earlier or more pronounced movement and balance problems.
How variants are linked to conditions
Variants in the SPG7 gene can cause hereditary spastic paraplegia type 7, an inherited condition that often leads to gradually increasing leg stiffness, weakness, and trouble walking. Some people also develop balance problems, slurred speech, or vision changes. When two disease-causing SPG7 variants are found, this SPG7-related hereditary spastic paraplegia diagnosis can be confirmed.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SPG7-related conditions, risk is mainly shaped by the gene changes you inherit, especially when both copies of the SPG7 gene are affected. Symptoms and severity can vary from one person to another, but clear lifestyle or environmental factors that change the chance of developing the condition have not been firmly established.
Inheritance of SPG7 variants
Variants in the SPG7 gene are usually inherited in an autosomal recessive pattern. For families asking how are variants of the SPG7 gene inherited, this means a person typically inherits one changed copy from each parent. Parents who each carry one SPG7 variant usually do not have the condition themselves. With each pregnancy, two carrier parents have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant.
What does my SPG7 result mean for my family?
For SPG7, family implications usually fit a recessive pattern. Parents of someone with a disease-causing SPG7 result are often healthy carriers, and brothers and sisters may also be carriers or, less often, also have the condition. Children are usually carriers if the other parent does not also carry a disease-causing SPG7 change. More distant relatives may also carry the same change in some families.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SPG7 gene, doctors use genetic testing for SPG7 variants on a blood or saliva sample. A lab reads the gene's DNA sequence and may also check for missing or extra pieces. Results can show whether no relevant variant was found, one variant was found, or two disease-causing variants were identified.
When should I consider getting a genetic test?
Consider testing for changes in the SPG7 gene if you or a close relative has ongoing leg stiffness and weakness, trouble walking, or balance problems that suggest an inherited condition affecting movement, sometimes called hereditary spastic paraplegia. It can also help explain symptoms when the cause is still unclear.
A genetic result is only one part of your health story
A genetic result may provide valuable insight, but how much it can explain varies depending on the condition and the kind of variant involved. Other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, have less effect in another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a medication. These differences are common and can influence both how well a treatment works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. By studying gene and drug patterns, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects may be. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the SPG7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response, so any concerns about symptoms, side effects, or treatment choices are best discussed with your doctor or pharmacist.
History
The SPG7 gene came to medical attention through studies of families with inherited stiffness and weakness in the legs, a group of conditions now called hereditary spastic paraplegia. In the late 1990s, researchers identified SPG7 as the cause of one form of this condition and linked it to a protein called paraplegin. Building on this early work, scientists uncovered more about the gene by showing that paraplegin works inside mitochondria, the parts of cells that help produce energy. This was an important step because it connected hereditary spastic paraplegia with problems in mitochondrial function. Over time, descriptions became more precise, and SPG7 was also linked to broader patterns that can include balance problems and changes in vision in some people.